Patents by Inventor Cheryl A. Conover

Cheryl A. Conover has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Marker for inflammatory conditions
    Patent number: 8323913
    Abstract: Use of pregnancy-associated plasma protein-A as a marker for inflammatory conditions, and in particular, for acute coronary syndromes is described.
    Type: Grant
    Filed: May 9, 2011
    Date of Patent: December 4, 2012
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Cheryl A. Conover, Antonio Bayes-Genis, David R. Holmes, Robert S. Schwartz
  • MARKER FOR INFLAMMATORY CONDITIONS
    Publication number: 20110212024
    Abstract: Use of pregnancy-associated plasma protein-A as a marker for inflammatory conditions, and in particular, for acute coronary syndromes is described.
    Type: Application
    Filed: May 9, 2011
    Publication date: September 1, 2011
    Inventors: Cheryl A. Conover, Antonio Bayes-Genis, David R. Holmes, Robert S. Schwartz
  • Marker for inflammatory conditions
    Patent number: 7939280
    Abstract: Use of pregnancy-associated plasma protein-A as a marker for inflammatory conditions, and in particular, for acute coronary syndromes is described.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: May 10, 2011
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Cheryl A Conover, Antonio Bayes-Genis, David R Holmes, Robert S Schwartz
  • MARKER FOR INFLAMMATORY CONDITIONS
    Publication number: 20100285510
    Abstract: Use of pregnancy-associated plasma protein-A as a marker for inflammatory conditions, and in particular, for acute coronary syndromes is described.
    Type: Application
    Filed: May 24, 2010
    Publication date: November 11, 2010
    Inventors: Cheryl A. Conover, Antonio Bayes-Genis, David R. Holmes, Robert S. Schwartz
  • Marker for inflammatory conditions
    Patent number: 7723049
    Abstract: Use of pregnancy-associated plasma protein-A as a marker for inflammatory conditions, and in particular, for acute coronary syndromes is described.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: May 25, 2010
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Cheryl A. Conover, Antonio Bayes-Genis, David R. Holmes, Robert S. Schwartz
  • Marker for Inflammatory Conditions
    Publication number: 20090197342
    Abstract: Use of pregnancy-associated plasma protein-A as a marker for inflammatory conditions, and in particular, for acute coronary syndromes is described.
    Type: Application
    Filed: February 20, 2009
    Publication date: August 6, 2009
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Cheryl A. Conover, Antonio Bayes-Genis, David R. Holmes, Robert S. Schwartz
  • Methods of Screening for Atherosclerosis
    Publication number: 20090191640
    Abstract: Methods for screening for altered focal proliferation states in non-pregnant patients, which include detecting levels of pregnancy-associated plasma protein-A (PAPP-A), are described. Methods for identifying agents that alter the protease activity of PAPP-A, and pharmaceutical compositions and medical devices that include such agents also are described.
    Type: Application
    Filed: February 23, 2009
    Publication date: July 30, 2009
    Inventors: Michael Toft Overgaard, Claus Oxvig, Cheryl A Conover
  • Methods of detecting ovarian neoplasia
    Patent number: 7462458
    Abstract: Methods for diagnosing ovarian neoplasia, monitoring ovarian cancer therapy, and monitoring progression of disease in subjects based on the level of the proform of major basic protein in biological samples from the subjects are described.
    Type: Grant
    Filed: May 15, 2003
    Date of Patent: December 9, 2008
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Cheryl A. Conover, Kimberly R. Kalli
  • Longevity and PAPP-A
    Patent number: 7402724
    Abstract: This document provides materials and methods related to PAPP-A polypeptides, aging, and transgenic non-human mammals whose genomes comprise a disrupted PAPP-A allele. Methods for making such transgenic non-human mammals, and using them and other mammals to identify and characterize agents that affect conditions related to PAPP-A activity, such as vascular restenosis, atherosclerosis, wound healing, cancer, fibrosis, bone development, fetal development, longevity, and fracture repair, also are provided.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: July 22, 2008
    Assignee: Mayo Foundation for Medical Education and Research
    Inventor: Cheryl A. Conover
  • Transgenic mouse lacking PAPP-A activity
    Patent number: 7220892
    Abstract: The invention provides materials and methods related to a transgenic non-human mammal whose genome comprises a disrupted PAPP-A allele. Methods for making such transgenic non-human mammals, and using them identify and characterize agents that affect conditions related to PAPP-A activity, such as vascular restenosis, atherosclerosis, wound healing, cancer, fibrosis, bone development, fetal development, longevity, and fracture repair, also are provided.
    Type: Grant
    Filed: January 3, 2003
    Date of Patent: May 22, 2007
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Cheryl A. Conover, Jan Van Deursen
  • Method for detecting IGFBP-4 protease without detecting IGFBP-4 protease/proMBP Complex
    Patent number: 7115382
    Abstract: Methods for screening for altered focal proliferation states in non-pregnant patients, which include detecting levels of pregnancy-associated plasma protein-A (PAPP-A) are described. Methods for identifying agents that alter the protease activity of PAPP-A, and pharmaceutical compositions and medical devices that include such agents are also described.
    Type: Grant
    Filed: March 15, 2000
    Date of Patent: October 3, 2006
    Assignees: Mayo Foundation for Medical Education and Research, Como Holdings APS
    Inventors: Michael Toft Overgaard, Claus Oxvig, Cheryl A. Conover
  • Treatment of osteoporosis
    Patent number: 6916790
    Abstract: A substantially pure complex including IGFIIE polypeptide and IGFBP2 polypeptide is described. Methods for treating an osteoporosis patient and targeting a compound to the skeletal extracellular matrix of a patient are also described.
    Type: Grant
    Filed: October 5, 2001
    Date of Patent: July 12, 2005
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Sundeep Khosla, Cheryl A. Conover, Francis J. Ballard, Peter M. Tapley
  • Marker for inflammatory conditions
    Publication number: 20040197844
    Abstract: Use of pregnancy-associated plasma protein-A as a marker for inflammatory conditions, and in particular, for acute coronary syndromes is described.
    Type: Application
    Filed: January 29, 2004
    Publication date: October 7, 2004
    Applicant: Mayo Foundation for Medical Education and Research, a Minnesota Corporation
    Inventors: Cheryl A. Conover, Antonio Bayes-Genis, David R. Holmes, Robert S. Schwartz
  • Treatment of osteoporosis
    Patent number: 6548482
    Abstract: A substantially pure complex including IGFIIE polypeptide and IGFBP2 polypeptide is described. Methods for treating an osteoporosis patient and targeting a compound to the skeletal extracellular matrix of a patient are also described.
    Type: Grant
    Filed: October 27, 1999
    Date of Patent: April 15, 2003
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Sundeep Khosla, Cheryl A. Conover, Francis J. Ballard, Peter M. Tapley
  • Marker for inflammatory conditions
    Patent number: 6500630
    Abstract: Use of pregnancy-associated plasma protein-A as a marker for inflammatory conditions, and in particular, for acute coronary syndromes is described.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: December 31, 2002
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Cheryl A. Conover, Antonio Bayes-Genis, Robert S. Schwartz
  • Treatment of osteoporosis
    Publication number: 20020151490
    Abstract: A substantially pure complex including IGFIIE polypeptide and IGFBP2 polypeptide is described. Methods for treating an osteoporosis patient and targeting a compound to the skeletal extracellular matrix of a patient are also described.
    Type: Application
    Filed: October 5, 2001
    Publication date: October 17, 2002
    Inventors: Sundeep Khosla, Cheryl A. Conover, Francis J. Ballard, Peter M. Tapley
  • MARKER FOR INFLAMMATORY CONDITIONS
    Publication number: 20020132278
    Abstract: Use of pregnancy-associated plasma protein-A as a marker for inflammatory conditions, and in particular, for acute coronary syndromes is described.
    Type: Application
    Filed: January 12, 2001
    Publication date: September 19, 2002
    Inventors: Cheryl A. Conover, Antonio Bayes-Genis, David R. Holmes, Robert S. Schwartz
  • Treatment of osteoporosis
    Patent number: 5998369
    Abstract: A substantially pure complex including IGFIIE polypeptide and IGFBP2 polypeptide is described. Methods for treating an osteoporosis patient and targeting a compound to the skeletal extracellular matrix of a patient are also described.
    Type: Grant
    Filed: May 5, 1998
    Date of Patent: December 7, 1999
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Sundeep Khosla, Cheryl A. Conover